Archive of Issues
Authors having problems with submissions please notify editor: editor@hvt-journal.com
Upcoming discussions, debates

On sweet undeniable feeling of power of international intellectual feudalism, bias, discrimination, censoring and theft

 

Vol 4 ( 2020 ); Issue 2

Published: 10/06/2020

Issue Articles

MISCELLANEOUS

Content page

Full Text   |   PDF


EDITORIALS

From Editor-in-Chief: On Covid-19 pandemics and welcome to new editors

We would like to welcome our new editors: on cardiovascular diseases, pulmonary disease and pulmonary hypertension – Dr Baktybek Kojonazarov from Gessen, Germany; on cardiovascular surgery - Dr Jeffrey Shuhaiber from Boston MA, USA; on cardiology and high-altitude medicine - Prof. Akpay Sarybaev, Bishkek, Kyrgyzstan and on nuclear cardiology and cardiology - Dr Andrea Rocha de Lorenzo from Rio de Janeiro, Brazil. Our team of editors’ feels enriched with invaluable expertise of our new members.

Full Text   |   PDF


EDITORIALS

The epidemiological situation of COVID-19 in the Kyrgyz Republic

The maximum number of cases of coronavirus infection was 79 (tested positive cases, including asymptomatic and cases with clinical manifestations) as of April 12, 2020. According to the forecast by the WHO methodology, the peak incidence of COVID-19 should be at the eighth week of the development of the epidemic process, amounting to 92 cases. Starting from the fifth week, the number of cases of COVID-19 tends to decrease gradually and the mathematical model for predicting the incidence of COVID-19 in the Kyrgyz Republic shows that by the end of May 2020, 97% of the total number of infected with coronavirus will be detected.

Full Text   |   PDF


EDITORIALS

COVID-19 and the cardiovascular system

The understanding of the pathophysiology of cardiovascular complications in COVID-19 is a key to the implementation of therapeutic measures, which may offer additional benefits, mainly for patients with severe disease, such as anticoagulants.

Full Text   |   PDF


ORIGINAL RESEARCH ARTICLE

Remodeling of the left heart in patients with rheumatic mitral valve disease after mitral valve replacement with preservation of subvalvular structures

This study shows the possibility of implanting the right size of the artificial heart valve, with rheumatic lesions of the mitral valve with the complete preservation of subvalvular structures.

Full Text   |   PDF


ORIGINAL RESEARCH ARTICLE

The effects of nutritional support for premature babies with ELBW and VLBW with hypoxic damage to the central nervous system

The aim of this investigation is to study clinical, laboratory, neurosonography and electroencephalography characteristics of preterm infants with VLBW and ELBW with hypoxic of CNS on complex comprehensive nutritional support, diagnostic criteria of which were infants body weight gain, increase in growth and head circumference

Full Text   |   PDF


REVIEW

Athletic heart adaptation, pathological hypertrophy and sudden cardiac death

In this review, we aimed to represent recent physiological and clinical standpoints regarding to athletic heart syndrome as well as its difference from sedentary heart changes and pathological hypertrophy, its association with sudden cardiac death.

Full Text   |   PDF


CASE REPORT

Results of surgical correction of gigantic left atrium

Thus, our case demonstrated reduction of left atrium early in postoperative period and its slow reduction after surgery during 1 year. It is also showed human reserve capacity and possibility of left atrial dilatation to such sizes. Late diagnosis of such changes in heart is possibly related to the fact that patient was afraid to see doctors and undergo surgery. The left atrial cavity size determination can be done intraoperatively using method of surgical glove we suggested.

Full Text   |   PDF


QUIZ

Quiz: Carotid artery ultrasound

Full Text   |   PDF


CASE REPORT

Severe bradyarrhythmia requiring temporary pacemaker in a COVID-19 patient receiving lopinavir/ritonavir treatment: a case report

This case highlights it is necessary to investigate balance between efficacy and safety of lopinavir/ritonavir for COVID-19 therapy. Off –label prescribing lopinavir/ritonavir outside of a clinical trial setting should be avoided until the data have proven that treatment benefit over placebo.

Full Text   |   PDF


QUIZ

Answers to the Quiz: Carotid artery ultrasound on page…

Full Text   |   PDF


MISCELLANEOUS

Reviewers and editors volume 4 issue 2 June 2020

Full Text   |   PDF